Strata Critical Medical, Inc. (SRTA) vs YD Bio Limited Ordinary Shares (YDES)
A side-by-side comparison of Strata Critical Medical, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SRTA
Strata Critical Medical, Inc.
$4.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
YDES
YD Bio Limited Ordinary Shares
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SRTA vs YDES
growth of $100 · dividends reinvested · last 1ySRTA +8.6% (+8.6%/yr)YDES -40.9% (-40.9%/yr)SRTA compounded faster over this window
SRTA YDES
SRTA vs YDES: by the numbers
- •YDES is the larger company ($436M vs $411M market cap).
- •SRTA is profitable (15.71% net margin) while YDES runs a net loss (-1392.61%).
Metrics side by side
Valuation
| Metric | SRTA | YDES |
|---|---|---|
| P/E ratio | 9.54 | N/A |
| P/S ratio | 1.61 | N/A |
| P/B ratio | 1.47 | N/A |
Profitability
| Metric | SRTA | YDES |
|---|---|---|
| Gross margin | 20.56% | -7.06% |
| Operating margin | -7.97% | -883.31% |
| Net margin | 15.71% | -1392.61% |
| ROE | 14.40% | -66.49% |
| ROIC | -7.11% | N/A |
Growth (annualized)
| Metric | SRTA | YDES |
|---|---|---|
| Revenue CAGR (5Y) | 46.05% | N/A |
| Total return CAGR (5Y) | -13.77% | N/A |
Frequently asked
- Is SRTA or YDES more profitable?
- SRTA runs the higher net margin — SRTA at 15.71% versus YDES at -1392.61%.
Go deeper
Dig into the metrics
Strata Critical Medical P/E ratioStrata Critical Medical ROEYD Bio Limited Ordinary Shares ROEStrata Critical Medical operating marginYD Bio Limited Ordinary Shares operating marginStrata Critical Medical revenue growthYD Bio Limited Ordinary Shares revenue growthStrata Critical Medical free cash flowYD Bio Limited Ordinary Shares free cash flow
Strata Critical Medical & YD Bio Limited Ordinary Shares appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.